Markets

ANI Pharmaceuticals (ANIP) in Focus: Stock Surges 10.5%

ANI Pharmaceuticals, Inc.ANIP was a big mover last session, as the company saw its shares surge over 10% on the day. Shares gained after the company's board authorized a stock repurchase program worth $25 million. The news led to far more shares changing hands than in a normal session resulting in solid volume. This continues the recent uptrend for the company as the stock is now up 23.8% in the past five days.

None of the estimates for this biomedical stock were revised over the past 30 days. The Zacks Consensus Estimate also remained unchanged over the same time frame. Yesterday's price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

ANI Pharmaceuticals currently carries a Zacks Rank #5 (Strong Sell), while its Earnings ESP is 0.00%.

A better-ranked stock in the same industry is Anika Therapeutics Inc. ANIK , sporting a Zacks Rank #1 (Strong Buy).

Is ANIP going up? Or down? Predict to see what others think: Up or Down

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days . Click to get this free report >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

ANIKA THERAPEUT (ANIK): Free Stock Analysis Report

ANI PHARMACEUT (ANIP): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

ANIK ANIP

Other Topics

Investing Stocks

Latest Markets Videos

    Zacks

    Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. In 1978, our founder discovered the power of earnings estimate revisions to enable profitable investment decisions. Today, that discovery is still the heart of the Zacks Rank. A wealth of resources for individual investors is available at www.zacks.com.

    Learn More